Workflow from Scientific Research

Open access visualization of Workflow, Flowchart, Kaplan-Meier Curve, Overall Survival, Atezolizumab
CC-BY
0
Views
0
Likes

Citation

DOI: 10.1016/s2589-7500(22)00231-x

DOI

Kaplan-Meier curves for overall survival (OS) in the IMpower150 study. Patients in the atezolizumab, bevacizumab, carboplatin, and paclitaxel (ABCP) arm experienced significantly longer OS compared to those in the bevacizumab, carboplatin, and paclitaxel (BCP) arm (HR 0.78, 95% CI 0.64-0.96; p = 0.0164).

#Workflow#Flowchart#Kaplan-Meier Curve#Overall Survival#Atezolizumab#Bevacizumab#Carboplatin#Paclitaxel#IMpower150 Study

Related Plots

Discover More Scientific Plots

Browse thousands of high-quality scientific visualizations from open-access research

Browse All PlotsView Collections